Alan Baumel - 15 Jun 2022 Form 4 Insider Report for HeartBeam, Inc. (BEAT)

Reporting relationship: Chief Operating Officer
Issuer ticker: BEAT
Reported as of: 15 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jun 2022, 18:59:24 UTC
Prior SEC filing: 23 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Alan Baumel

Key filing fact

Alan Baumel filed Form 4 for HeartBeam, Inc. (BEAT) on 17 Jun 2022.

Key facts

This page summarizes Alan Baumel's Form 4 filing for HeartBeam, Inc. (BEAT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Jun 2022, 18:59.

Change

Previous filing in this sequence was filed on 23 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BEAT transaction Derivative

Stock option (right to buy)

Award

Transaction value: $0
Shares: +38,000
Change %
Price: $0.000000
Shares after: 38,000
Date: 15 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,000
Exercise price: $1.30
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The options ("Options") have been issued from the 2022 Executive Incentive Plan, that was approved at the Annual Shareholder Meeting held on June 15, 2022.

Footnote F2

The Option will vest and become exercisable with respect to 25% of the shares starting June 15, 2023 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date, such that 100% of the shares shall be fully vested and exercisable on June 15, 2027. All Options shall accelerate and vest in full upon the Company's termination of the Reporting Person's engagement with the Company following a change in control.